Shaffer P M, Hsu C A, Abbott M T
J Bacteriol. 1975 Feb;121(2):648-55. doi: 10.1128/jb.121.2.648-655.1975.
The experiments in this report involve the following series of reactions which were previously demonstrated with purified enzyme preparations from Neurospora crassa: thymidine a yields thymine ribonucleoside b yields thymine c yields 5-hydroxymethyluracil d yields 5-formyluracil e yields uracil-5-carboxylic acid f yields uracil. The evidence for some of the reactions occurring in vivo has been incomplete and for others totally lacking. In this paper intact cells of Neurospora are shown to be capable of converting the substrates of each of the reactions to the corresponding products. Studies are described which were carried out in vivo and in vitro with the pyrimidineless strains pyr-4,uc-1,uc-2 and pyr-4,uc-1,uc-3, developed by Williams and Mitchell. The results reported in the present paper indicate that (reaction a) and the uc-3 mutation affects thymine 7-hydroxylase (reactions c,d, and e). Evidence is presented for the 2'-hydroxylase reaction being the major, if not only, way by which Neurospora can initiate the conversion of thymidine to the pyrimidines of nucleic acids and for the 2'-hydroxylation of thymidine and deoxyuridine being catalyzed by the same enzyme. Deoxycytidine was shown not to be hydroxylated in intact cells but instead deaminated to deoxyuridine, which in turn was converted to uridine. Further studies with the uc-3-carrying strain showed that an enzyme other than thymine 7-hydroxylase can also convert 5-formyluracil to uracil-5-carboxylic acid.
本报告中的实验涉及以下一系列反应,这些反应先前已在粗糙脉孢菌的纯化酶制剂中得到证实:胸腺嘧啶核苷a生成胸腺嘧啶核糖核苷b生成胸腺嘧啶c生成5-羟甲基尿嘧啶d生成5-甲酰基尿嘧啶e生成尿嘧啶-5-羧酸f生成尿嘧啶。关于某些反应在体内发生的证据尚不完整,而对于其他反应则完全缺乏证据。本文表明,粗糙脉孢菌的完整细胞能够将每个反应的底物转化为相应的产物。文中描述了对Williams和Mitchell培育的无嘧啶菌株pyr-4、uc-1、uc-2和pyr-4、uc-1、uc-3进行的体内和体外研究。本文报道的结果表明,(反应a)以及uc-3突变影响胸腺嘧啶7-羟化酶(反应c、d和e)。有证据表明,2'-羟化酶反应是粗糙脉孢菌启动胸腺嘧啶核苷向核酸嘧啶转化的主要方式(如果不是唯一方式的话),并且胸腺嘧啶核苷和脱氧尿苷的2'-羟化由同一种酶催化。完整细胞中的脱氧胞苷未被羟化,而是脱氨基生成脱氧尿苷,脱氧尿苷进而转化为尿苷。对携带uc-3的菌株的进一步研究表明,除胸腺嘧啶7-羟化酶外,另一种酶也能将5-甲酰基尿嘧啶转化为尿嘧啶-5-羧酸。